<DOC>
<DOCNO>
EP-0008899
</DOCNO>
<TEXT>
<DATE>
19800319
</DATE>
<IPC-CLASSIFICATIONS>
C07D-503/00 A61K-31/545 <main>C07D-498/04</main> A61K-31/43 A61K-31/42 
</IPC-CLASSIFICATIONS>
<TITLE>
clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
beecham group ltdgb<sep>beecham group limited<sep>beecham group plcbeecham house, great west roadbrentford, middlesex tw8 9bdgb<sep>beecham group plc<sep>
</APPLICANT>
<INVENTOR>
davies john sydney<sep>zomaya iskander ishu<sep>davies, john sydney<sep>zomaya, iskander ishu<sep>davies, john sydney17 beaufort roadreigate, surreygb<sep>zomaya, iskander ishu19 purdey court the avenueworcester park, surreygb<sep>davies, john sydney<sep>zomaya, iskander ishu  <sep>davies, john sydney 17 beaufort roadreigate, surreygb<sep>zomaya, iskander ishu19 purdey court the avenueworcester park, surreygb<sep>
</INVENTOR>
<ABSTRACT>
the compounds of the formula (i):    and salts and esters thereof wherein r₁ is a hydrogen atom  or a lower alkyl, aryl or aralkyl group, r₂ and r₃ are indepen­ dantly hydrogen, aryl, aralkyl, lower alkyl or substituted  lower alkyl, or r₃ is joined to r₁ to form a 5- or 6- membered  ring and x is s, so or so₂; have been found to be  β-lactamase inhibitors and antibacterial agents.  their prep­ aration and use is described.  
</ABSTRACT>
</TEXT>
</DOC>
